Dramatic Deterioration of Subclinical Hyperparathyroidism in Children and Adolescents During the Post-COVID-19 Period.

Publication date: Jun 27, 2025

Background: Vitamin D is a steroid hormone, essential for the immune system and bone health. Since the sun is meant to provide at least 80% of daily vitamin D requirements, the COVID-19 pandemic is likely to have induced a considerable influence on calcium metabolism. Methods: We analyzed data from 1138 children, seen in an outpatient pediatric endocrinology clinic from 2022-2023. Vitamin D status was classified as deficiency if 25(OH)D ≤ 20 ng/mL, insufficiency < 30 ng/mL, and sufficiency ≥ 30 ng/mL. Results: Overall, 60. 8% of children had vitamin D deficiency or insufficiency worsened with age (p < 0. 005), and with adolescent males having higher 25(OH)D concentrations than females (p < 0. 05). A negative correlation was found between 25(OH)D and BMI SDS (R = 0. 02, p < 0. 001), and 25(OH)D concentrations varied seasonally, decreasing in winter. Subclinical hyperparathyroidism [parathyroid hormone (PTH) > 45 pg/mL) and normal calcium] was found in 21. 5% of children, with 73. 5% of them being vitamin D deficient or insufficient. A negative correlation between PTH and 25(OH)D was observed, with PTH plateauing at 25(OH)D above 40 ng/mL (p < 0. 001). Conclusions: Compared to the pre-pandemic data (2016-2018), with only 5. 1% of children having subclinical hyperparathyroidism (p < 0. 001), these findings suggest a marked deterioration in vitamin D status and calcium metabolism in children, with possible unforeseen consequences for bone, immune, and general health.

Open Access PDF

Concepts Keywords
Hyperparathyroidism bone health
Outpatient normocalcemic hyperparathyroidism
Vitamin rickets
Winter subclinical hyperparathyroidism
vitamin D
vitamin D deficiency
vitamin D insufficiency

Semantics

Type Source Name
disease MESH Hyperparathyroidism
disease MESH COVID-19
drug DRUGBANK Vitamin D
pathway REACTOME Immune System
drug DRUGBANK Calcium
pathway REACTOME Metabolism
disease MESH vitamin D deficiency
drug DRUGBANK Sodium lauryl sulfate
drug DRUGBANK Parathyroid hormone
disease MESH general health
drug DRUGBANK Coenzyme M
disease MESH vitamin deficiency
disease MESH rickets
drug DRUGBANK Ergocalciferol
drug DRUGBANK Cholecalciferol
drug DRUGBANK Water
drug DRUGBANK Phosphorus
disease MESH aids
disease MESH hypocalcemia
disease MESH hyperparathyroidism 3
disease MESH infection
disease MESH hypertension
disease MESH metabolic syndrome
disease MESH autoimmune diseases
disease MESH multiple sclerosis
disease MESH rheumatoid arthritis
pathway KEGG Rheumatoid arthritis
drug DRUGBANK Calcitriol
disease IDO history
disease MESH metabolic bone diseases
disease MESH inflammatory bowel disease
pathway KEGG Inflammatory bowel disease
disease MESH celiac disease
disease MESH malabsorption syndromes
disease MESH hypercalcemia
disease MESH hypoparathyroidism

Original Article

(Visited 1 times, 1 visits today)